US2013274453A1PendingUtilityA1
Detection of Degradation Products of Feline NT-proBNP
Est. expiryMay 31, 2031(~4.8 yrs left)· nominal 20-yr term from priority
G01N 33/74G01N 2333/58G01N 2800/32G01N 33/54306
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for determining the amount of NT-proBNP in blood samples from felines. The method includes detecting degradation products of feline NT-proBNP by various methods, including using antibodies, kits and devices.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An immunoassay device comprising a solid support having a first antibody bound thereto a first antibody specific for a fragment of feline NT-proBNP selected from the group consisting of:
(SEQ ID NO: 5)
ASEASAIQELLDGLRDTVSEL;
(SEQ ID NO: 9)
LGPLQQGHSPAESWEAQEEPPARVLAPHDNVLR;
and
(SEQ ID NO: 10)
LQQGHSPAESWEAQEEPPARVLAPHDNVLR.
2 . The device of claim 1 , wherein the first antibody is specific for SEQ ID NO: 5.
3 . The device of claim 1 , wherein the first antibody is specific for SEQ ID NO:9.
4 . The device of claim 1 , wherein the first antibody is specific for SEQ ID NO:10.
5 . The device of claim 1 , wherein the first antibody is a monoclonal antibody.
6 . The device of claim 5 , wherein the first antibody is raised against the fragment of feline NT-proBNP.
7 . The device of claim 1 , wherein the first antibody is a polyclonal antibody.
8 . The device of claim 7 , wherein the first antibody is raised the fragment of feline NT-proBNP.
9 . The device of claim 1 , further comprising a second antibody being specific for the fragment of feline NT-proBNP.
10 . The device of claim 9 , wherein the second antibody is a monoclonal antibody.
11 . The device of claim 10 , wherein the monoclonal antibody is raised the fragment of feline NT-proBNP.
12 . The device of claim 9 , wherein the second antibody is a polyclonal antibody.
13 . The device of claim 12 , wherein the second antibody is raised the fragment of feline NT-proBNP.
14 . The device of claim 9 , wherein the second antibody is labeled.
15 . The device of claim 1 , further comprising a labeled detection reagent that competes with the fragment for binding with the first antibody.
16 . The device of claim 15 , wherein the first antibody is specific for SEQ ID NO: 5.
17 . The device of claim 15 , wherein the first antibody is specific for SEQ ID NO:9.
18 . The device of claim 15 , wherein the first antibody is specific for SEQ ID NO:10.
19 . The device of claim 15 , wherein the first antibody is a monoclonal antibody.
20 . The device of claim 15 , wherein the first antibody is a polyclonal antibody.Join the waitlist — get patent alerts
Track US2013274453A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.